Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D003520 |
Cyclophosphamide |
SCUBE2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of SCUBE2 mRNA | increases expression | 18042831
|
D004317 |
Doxorubicin |
SCUBE2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D005472 |
Fluorouracil |
SCUBE2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D017239 |
Paclitaxel |
SCUBE2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
C041786 |
palm oil |
palm oil results in increased expression of SCUBE2 mRNA | increases expression | 18042831
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.83 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.83 | 17638652 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.93 | 21441931 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
4.02 | 17963324 16511603 15504547 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
11.76 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
11.76 | 15238619 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.22 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.92 | 15867366 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.11 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.45 | 15136595 11325840 15093573 18323546 17020986 17388661 16978400 18234424 12006526 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.45 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.45 | 15692762 16115903 18234424 19526202 16322301 17369602 17426702 15939500 18382427 16096432 15993339 18628466 15567936 17983394 11325840 16264153 15136595 18695136 16826403 15668708 16935488 15994142 15634643 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.45 | 18357371 16557594 19217205 16595493 16110121 15136595 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.45 | 16115903 15136595 18234424 16244791 11325840 18323546 18223236 16273361 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
14.15 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
14.15 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
3.82 | 17121937 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
7.02 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
7.02 | 18059187 16023760 17876044 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
7.02 | 16799960 17045692 16332177 17088986 18930000 17971768 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
7.02 | 16313753 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
5.35 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
11.64 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
11.64 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
11.64 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
5.10 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
5.10 | 16280240 17066447 18986760 16757204 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.72 | 16109756 15476868 16952015 16364871 17974986 17351982 17928571 16731534 15792986 18627295 16242529 16651473 17382496 17007740 17924179 16612575 16269455 17131338 16278810 17308081 15505089 17329180 15811867 17519947 16455267 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.03 | 16243910 17334414 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.27 | 17725105 18772588 15001691 17169374 16510598 17016597 16340194 17287894 17018589 17172411 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.68 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.68 | 17094418 20501625 15289873 16303861 17016601 18802399 17255274 18383874 17594712 18509181 16331619 16391804 17401013 16524972 14970324 17695437 18448328 17454858 15148649 16282729 18949393 18288408 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
3.68 | 18802399 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.51 | 12913760 15276878 16651033 18372110 16614059 12388444 18433785 18483878 10498854 18295254 18093676 10700343 16413132 16989017 17010015 11948286 18710439 17979934 15643279 12161096 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.25 | 16733453 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.33 | 11751995 10990075 15331540 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.29 | 18772604 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
2.51 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.90 | 18602426 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.67 | 18367378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.64 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.68 | 18037988 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.63 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
5.03 | 16337965 16481741 16785472 17638652 15173087 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
5.03 | 16481741 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
3.56 | 19004024 18296743 19551842 17967931 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
5.05 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
3.94 | 18296743 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.54 | 17150277 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.97 | 16145905 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.98 | 11389073 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.45 | 11014644 16376943 15172196 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
8.60 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
8.60 | 18337622 15162350 15102660 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.69 | 16330681 16244371 16244372 18006777 16879835 16144979 12587719 17888722 16495754 17875725 16707910 18674790 14766674 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.52 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.23 | 15692506 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.71 | 11918545 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
6.05 | 14986274 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
8.67 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
8.67 | 17606976 15147373 18501091 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.92 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.97 | 21332399 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.85 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
3.82 | 16517039 7193160 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
2.57 | 20412841 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.30 | 18457598 11836018 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.21 | 15369732 16775033 15699352 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.48 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
3.57 | 16985049 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.62 | 10602166 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.68 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.61 | 18587576 17802794 17008537 18172266 17296974 17658394 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.32 | 10373061 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.43 | 10052129 11830472 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
5.17 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
3.03 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.15 | 16595196 16439617 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
2.57 | 16603448 17045692 15113037 18383874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.19 | 17085340 16842330 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.75 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
2.75 | 15246190 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.25 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
8.62 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
8.62 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.95 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
16.29 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
16.29 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
16.29 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.98 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.21 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.81 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
3.81 | 12025231 16342250 12040289 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
5.22 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.16 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.83 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.87 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.25 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.90 | 14749477 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.05 | 19429709 15857846 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.48 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
6.48 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
5.87 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
5.87 | 18239605 18600527 16928823 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.19 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.29 | 16889571 15640375 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
7.69 | 16115947 8761367 15176712 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.69 | 15555623 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
5.35 | 8761367 12837982 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.64 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.68 | 8291058 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.34 | 20132043 17217161 19632207 21332399 18674790 18457598 11836018 16723640 20518802 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
5.17 | 16517039 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
5.44 | 15867366 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.37 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
3.06 | 11161223 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.89 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
5.92 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.92 | 19003803 16929163 16500647 15113037 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.68 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.68 | 17638057 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.96 | 21297632 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.13 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.13 | 18437689 16888761 15897917 15749863 16729912 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.13 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.13 | 17172428 16729912 16356831 17136230 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.38 | 16636934 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.30 | 16160472 18286688 15538739 18722050 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.64 | 17922066 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.29 | 16767912 17203757 15625365 15675481 17710206 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.62 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.25 | 17846226 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
5.17 | 16636934 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.08 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.98 | 17203757 16767912 15625365 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.98 | 16517039 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.81 | 18396642 19084572 18567086 17498489 17522103 16951190 17172411 15786421 19015929 16424979 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
2.81 | 18506536 18396642 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.52 | 12837982 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
5.27 | 16930453 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.61 | 17909728 16010429 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.29 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
5.84 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.84 | 17653716 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
4.18 | 16803524 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.64 | 17678736 17334414 17638931 16364871 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
4.02 | 16723640 |